Natural product growth inhibitors of Mycobacterium tuberculosis.
about
Tetrahdroxysqualene from Rhus taitensis shows antimycobacterial activity against Mycobacterium tuberculosisEvaluation of the anti-mycobacterium tuberculosis activity and in vivo acute toxicity of Annona sylvatic.Some Nigerian anti-tuberculosis ethnomedicines: a preliminary efficacy assessment.Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead.Are natural products still the best source for antibacterial discovery? The bacterial entry factor.Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatmentAntimycobacterial and HIV-1 Reverse Transcriptase Activity of Julianaceae and Clusiaceae Plant Species from Mexico.Efficacy of Artemisia afra phytotherapy in experimental tuberculosis.Terpenyl-purines from the sea.Natural products and Chagas' disease: a review of plant compounds studied for activity against Trypanosoma cruzi.Antimycobacterial susceptibility testing methods for natural products research.Predicting natural product value, an exploration of anti-TB drug space.Proteomic profile of Mycobacterium tuberculosis after eupomatenoid-5 induction reveals potential drug targets.Natural Compounds from Mexican Medicinal Plants as Potential Drug Leads for Anti-Tuberculosis Drugs.Anti-tumor effects of the peptide TMTP1-GG-D(KLAKLAK)(2) on highly metastatic cancers.Antimycobacterial activity of fusaric acid from a mangrove endophyte and its metal complexes.Anti-Mycobacterium tuberculosis activity of fungus Phomopsis stipata.Benzothiazines in synthesis. A formal total synthesis of pseudopteroxazole.Antiprotozoal and Antimycobacterial Activities of Pure Compounds from Aristolochia elegans Rhizomes.Stereochemical analysis of leubethanol, an anti-TB-active serrulatane, from Leucophyllum frutescens.Anti-tubercular screening of natural products from Colombian plants: 3-methoxynordomesticine, an inhibitor of MurE ligase of Mycobacterium tuberculosis.Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria.Antimycobacterial neolignans isolated from Aristolochia taliscana.Design and Synthesis of Some Novel Fluorobenzimidazoles Substituted with Structural Motifs Present in Physiologically Active Natural Products for Antitubercular Activity.Secondary metabolites from Triclisia gilletii (De Wild) Staner (Menispermaceae) with antimycobacterial activity against Mycobacterium tuberculosis.In vitro antituberculosis activity of diterpenoids from the Vietnamese medicinal plant Croton tonkinensis.Antituberculosis activity, phytochemical identification of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (DC. Ex Nees) Stapf., and Tabernaemontana coronaria (L.) Willd. and their effects on the growth kinetics and cellular integrity of MycobTotal Synthesis of Ileabethoxazole, Pseudopteroxazole, and seco-Pseudopteroxazole.The ethanolic extract of ashitaba stem (Angelica keskei [Miq.] Koidz) as future antituberculosis.Trixis angustifolia hexanic extract displays synergistic antibacterial activity against M. tuberculosis.Antimycobacterial, docking and molecular dynamic studies of pentacyclic triterpenes from Buddleja saligna leaves.Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.The uniqueness and therapeutic value of natural products from West African medicinal plants. Part I: uniqueness and chemotaxonomy
P2860
Q24645608-58B5C835-BA14-48A7-89CD-3F283B949053Q33849036-7B1B4F05-B3D3-4441-A4E8-E563C1C1735EQ34131209-41D8A634-D90E-4495-BDD6-E4B4DF646DE0Q34357575-25619B10-D535-44EB-B45B-9EC96147AAF3Q34619268-3BE1BC84-4073-483A-8216-E3C0C48392FDQ35010528-2BAF3916-0F0C-47C2-831D-41A8B81DF180Q35578829-75445711-9E8B-4F35-9208-A131B99F7D83Q36226079-FDB570B9-E658-4E91-B8A1-8AE99388C78CQ37680690-49E25933-B357-4F5D-8527-3B167EAD546EQ37835034-8886BA38-DDE1-4987-AA9A-253A7D281CB1Q38137055-E3DCB98F-587A-4FFB-B3E6-49134F4AEF04Q38216493-11D5999F-261E-4B86-9D15-9047AE2610CAQ38661355-E8F261B4-6160-4C77-9D7E-D197A14DB45EQ39136416-E976F1CF-13E3-46BD-B5E0-BE6C853032EFQ39277451-4CF589A1-6A7A-47C4-9D4A-889B86277773Q39335467-B405933C-A072-4F75-891E-62606CD32A33Q39420000-99290B9E-E3DA-43C0-AC10-5650E92CB268Q41897665-02496F7D-D78A-4771-964E-E7846B8BE5FEQ42612800-7854AE54-30C5-40D1-BA61-AC0202D42DB2Q42727408-6C6FF85B-9642-4D70-B44F-7AC23CECBF6CQ42933739-499E8903-CA14-4282-9F5D-4BC3B40B3CC7Q42964446-3525DC32-65AD-40B1-8490-488816E2B43EQ44565103-81F365E8-13F7-4C34-9D89-F54DB0CBCD78Q45981578-09F0DB52-2B6F-4274-B90D-6B92B8CC5781Q46158818-78D1DDEF-3213-4643-A263-D583D2510029Q47378084-999E3788-0C1E-46EC-B173-747DB8A0123AQ47396139-24D5DFD5-2934-4595-82CA-63ED4F2FD363Q48255981-DE8E64DD-CAF7-4B10-960B-D8AD153FFD25Q49239495-5CFA3626-09B0-48FC-86A3-A39DC159B32DQ49582225-6F7F5C79-DFB8-4E96-9338-E45DBE3E5187Q50183793-C24B0D41-9B2D-4143-9603-2C1E060386D7Q50948654-105EA6A0-024D-41E7-B860-CB3B1DABC1D2Q58860065-70C8D68B-AAF3-455F-9837-FAF92AF301E8
P2860
Natural product growth inhibitors of Mycobacterium tuberculosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Natural product growth inhibitors of Mycobacterium tuberculosis.
@ast
Natural product growth inhibitors of Mycobacterium tuberculosis.
@en
type
label
Natural product growth inhibitors of Mycobacterium tuberculosis.
@ast
Natural product growth inhibitors of Mycobacterium tuberculosis.
@en
prefLabel
Natural product growth inhibitors of Mycobacterium tuberculosis.
@ast
Natural product growth inhibitors of Mycobacterium tuberculosis.
@en
P2860
P356
P1476
Natural product growth inhibitors of Mycobacterium tuberculosis
@en
P2093
A Norrie Pearce
P2860
P304
P356
10.1039/B513520F
P50
P577
2006-11-28T00:00:00Z